ENZ
$2.25
Enzo Biochem
$.04
1.81%
ENZ
Earnings Whisper ®
N/A
Consensus:  $0.00
Revenue:  N/A
Monday
Mar 9
4:05 PM ET
Score
Grade
Tweet Share Watch
Tweet Share Watch
Latest EPS

What do you expect when ENZ reports earnings?
Beat
Meet
Miss

Where is ENZ's stock price going from here?
Up
Flat
Down
Stock chart of ENZ
Analysts
Summary of analysts' recommendations for ENZ
Score
Grade
Pivots
Resistance
-
-
-

-

Support
-
-
-
Tweet
Growth
Description
Enzo Biochem, Inc. develops, manufactures and markets health care products based on molecular biology and genetic engineering techniques, and also provides diagnostic services to the medical community. The business activities of the company are performed by one of the company's three wholly-owned subsidiaries--Enzo Diagnostics, Inc., Enzo Therapeutics, Inc., and Enzo Clinical Labs, Inc. The primary focus of the company's research is the development of products based on two technology platforms -- genetic modulation and immune modulation.
Peers
Quest DiagnosticsLaboratory Corp. of America